Outcome of patients with early ovarian cancer undergoing three courses of adjuvant chemotherapy following complete surgical staging

International Journal of Gynecological Cancer

Volumn 15, Issue 4, 2005, Pages 601-605

  Shimada, M ^a   Kigawa, Junzo ^a   Kanamori, Y ^a   Itamochi, H ^a   Oishi, T ^a   Minagawa, Y ^b   Ishihara, K ^c   Takeuchi, Y ^d   Okada, M ^e   Terakawa, N ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b Tottori Prefectural Central Hospital   (Japan)

^c Yonago National Hospital   (Japan)

^d Mihara Red Cross Hospital   (Japan)

^e YAMAGUCHI RED CROSS HOSPITAL   (Japan)

Author keywords

Adjuvant chemotherapy; Complete surgical staging; Early ovarian cancer; Prognostic factor

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PACLITAXEL; PLATINUM DERIVATIVE;

ADULT; AGED; APPENDECTOMY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER STAGING; CANCER SURGERY; CLEAR CELL CARCINOMA; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; ENDOMETRIOID CARCINOMA; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MUCINOUS CARCINOMA; MULTIVARIATE ANALYSIS; OVARY CANCER; PARAAORTIC LYMPH NODE; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROGNOSIS; SALPINGOOOPHORECTOMY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PACLITAXEL; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 22544446158     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2005.00115.x     Document Type: Article

References (31)

1. Campo JM, Felip E, Rubio D et al. Long-term survival in advanced ovarian cancer after cytoreduction and chemotherapy. Gynecol Oncol 1994;53:1-5.
2. Ozols RF. Treatment of ovarian cancer: current status. Semin Oncol 1994;21:1-9.
3. Vaccarello L, Rubin SC, Vlammis V et al. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response. Gynecol Oncol 1995;57:61-5.
4. Kigawa J, Minagawa Y, Ishihara H et al. Evaluation of cytoreductive surgery with lymphadenectomy including para-aortic nodes for advanced ovarian cancer. Eur J Surg Oncol 1993;19:273-8.
5. Thigpen JT. Limited-stage ovarian carcinoma. Semin Oncol 1999;26:29-33.
6. Young RC, Pecorelli S. Management of early ovarian cancer. Semin Oncol 1998;25:335-9.
7. Monga M, Carmichael JA, Shelley WE et al. Surgery without chemotherapy for early epithelial ovarian carcinoma after comprehensive surgical staging. Gynecol Oncol 1991;43:195-7.
8. Le T, Krepart GV, Lotocki RJ et al. Clinically apparent early stage invasive epithelial ovarian carcinoma: should all be treated similarly. Gynecol Oncol 1999;74:252-4.
9. Young RC, Walton LA, Ellenberg SS et al. Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of prospective randomized trials. New Eng J Med 1990;322:1021-7.
10. Raymond E, Drolet Y, Marpeau L et al. Long-term follow-up after adjuvant chemotherapy in completely resected early stage ovarian carcinoma. Eur J Obstet Gynecol Reprod Biol 1997;72:181-90.
11. Bolis G, Colombo N, Pecorelli S et al. Adjuvant treatment for early epithelial ovarian cancer: results of two randomized clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P). Ann Oncol 1995;6:887-93.
12. Favalli G, Odicino F, Toni V et al. Early stage ovarian cancer: Italian contribution to clinical research. An update. Int J Gynecol Oncol 2001;11:12-9.
13. Trimbos JB, Parmar M, Vergote I et al. International Collaborative Ovarian Neoplasm trial 1 and Adjuvant Chemo Therapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J Natl Cancer Inst 2003;95:105-12.
14. Dexeus S, Cusido MT, Suris JC et al. Lymphadenectomy in ovarian cancer. Eur J Gynecol Oncol 2000;21:215-22.
15. Steinberg JJ, Demopoulos RI, Bigelow B et al. The evaluation of the omentum in ovarian cancer. Gynecol Oncol 1986;24:327-30.
16. Boente MP, Yeh K, Hogan WM et al. Current status of staging laparotomy in colorectal and ovarian cancer. Cancer Treat Res 1996;82:337-57.
17. Young RC. Three cycles versus six cycles of adjuvant paclitaxel (Taxol)/carboplatin in early stage ovarian cancer. Semin Oncol 2000;27:8-10.
18. Benda JA, Zaino R. GOG pathology manual. Buffalo, NY: Gynecologic Oncology Group, 1994:189.
19. Dembo AJ, Davy M, Stenwig AE et al. Prognostic factor in patients with stage I epithelial ovarian cancer. Obstet Gynecol 1990;75:263-73.
20. Sugiyama T, Kamura T, Kigawa J et al. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer 2000;88:2584-9.
21. Jenison EL, Montag AG, Griffiths CT et al. Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serous carcinoma. Gynecol Oncol 1989;32:65-71.
22. Behbakht K, Randall TC, Benjamin I et al. Clinical characteristics of clear cell carcinoma of the ovary. Gynecol Oncol 1989;32:65-71.
23. Kennedy AW, Biscotti CV, Hart WR et al. Ovarian clear cell adenocarcinoma. Gynecol Oncol 1989;32:342-9.
24. Crazier MA, Copeland LJ, Suva EG et al. Clear cell carcinoma of the ovary: a study of 59 cases. Gynecol Oncol 1989;35:199-203.
25. Behbakht K, Randall TC, Benjamin I et al. Clinical characteristics of clear cell carcinoma of the ovary. Gynecol Oncol 1998;70:255-8.
26. Ahmed FY, Wiltshaw E, A'Hern RP et al. Natural history and prognosis of untreated stage I epithelial ovarian carcinoma. J Clin Oncol 1996;14:2968-75.
27. Vergote I, De Brabanter J, Fyles A et al. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet 2001;357:176-82.
28. Munoz KA, Harlan LC, Trimble EL et al. Patterns of care for women with ovarian cancer in the United States. J Clin Oncol 1997;15:3408-15.
29. Trimbos JB, Vergote I, Bolis G et al. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. J Natl Cancer Inst 2003;15:113-25.
30. Young RC, Decker DG, Wharton JT et al. Staging laparotomy in early ovarian cancer. JAMA 1983;250:3072-6.
31. Helewa ME, Krepart GV, Lotocki R. Staging laparotomy in early epithelial ovarian carcinoma. Am J Obstet Gynecol 1986;154:282-6.